US Stock MarketDetailed Quotes

Akebia Therapeutics (AKBA)

Watchlist
  • 3.630
  • +0.010+0.28%
Close Jul 7 16:00 ET
  • 3.680
  • +0.050+1.38%
Post 19:57 ET
953.37MMarket Cap-17.29P/E (TTM)

About Akebia Therapeutics Company

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.

Company Profile

SymbolAKBA
Company NameAkebia Therapeutics
Listing DateMar 20, 2014
Issue Price17.00
ISINUS00972D1054
Founded2007
CEOMr. John P. Butler
MarketNASDAQ
Employees181
Fiscal Year Ends12-31
Address245 First Street,Suite 1400
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-871-2098

Company Executives

  • Name
  • Position
  • Salary
  • John P. Butler
  • Director, President and Chief Executive Officer
  • 4.26M
  • Richard C. Malabre
  • Senior Vice President and Chief Accounting Officer
  • --
  • Nicholas Grund
  • Senior Vice President and Chief Commercial Officer
  • 1.85M
  • Erik John Ostrowski
  • Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer
  • 1.22M
  • Dr. Steven Keith Burke, M.D.
  • Senior Vice President, Research and Development and Chief Medical Officer
  • 1.81M
  • Adrian Adams
  • Chairman of the Board
  • 165.33K
  • LeAnne M. Zumwalt
  • Independent Director
  • 137.83K
  • Cynthia Smith
  • Independent Director
  • 142.83K
  • Ronald E. Frieson
  • Independent Director
  • 142.83K
  • Michael W. Rogers
  • Independent Director
  • 142.83K
  • Dr. Steven C. Gilman, PhD
  • Independent Director
  • 135.33K
  • Dr. Myles Wolf, M.D.
  • Independent Director
  • 137.83K

Market Insights

AI application software AI application software

AI application software stocks refer to companies that utilize advanced algorithms and computing capabilities in the field of artificial intelligence to develop and provide innovative software solutions. Through the application of artificial intelligence technology, these companies have improved the efficiency and functionality of their products to meet the needs of different industries, such as automation, data analysis, customer service, etc. AI application software stocks refer to companies that utilize advanced algorithms and computing capabilities in the field of artificial intelligence to develop and provide innovative software solutions. Through the application of artificial intelligence technology, these companies have improved the efficiency and functionality of their products to meet the needs of different industries, such as automation, data analysis, customer service, etc.

Unlock Now

Discussing

The tariff deferral period has been extended! How have trade policies in various countries evolved?
On the 7th local time, U.S. President Trump signed an executive order extending the so-called "reciprocal tariff" delay period, postponing t Show More

focus on technology stocks

Top tech company strong as always.